Noasdaq and global asset manager Invesco are expanding their partnership with the launch of two new Exchange Traded Funds (ETFs), the Invesco Nasdaq Biotechnology ETF (IBBQ) and the Invesco PHLX Semiconductor ETF (SOXQ).
The new ETFs form the Nasdaq Biotechnology Index (NBI) and PHLX semiconductor sector index (SOX), both of which are the longest standing benchmarks for the respective topics that have become increasingly relevant in the wake of the global pandemic.
The biotech index tracks over 270 innovative companies listed on the Nasdaq stock exchange, including large, mid and small cap companies in every growth phase. Securities in IBBQ include Amgen (AMGN), Gilead Science (GILD), Lighting (ILMN), Vertex Pharmaceuticals (VRTX) and Moderna (MRNA). The semiconductor index now includes the 30 biggest names in semiconductor development and manufacture, such as Texas Instruments (TXN), Intel (INTC), Broadcom (AVGO), QUALCOMM (QCOM) and NVIDIA (NVDA).
“We are excited to expand our relationship with Nasdaq to give investors further access to the innovative companies that are currently shaping the way we live and work,” said Anna Paglia, global head of ETFs and Indexed Strategies at Invesco. “There has never been a more relevant moment to these two topics, and we are delighted that we have now been able to offer investors the most cost-effective way to invest in Nasdaq-listed companies through indices that have been live for nearly three decades.”
With the Invesco Nasdaq Biotechnology ETF and the Invesco PHLX Semiconductor ETF, Invesco aims to offer the most affordable products in their respective categories. While the new ETFs each have a total expense ratio of 19 basis points, Invesco, in cooperation with the Nasdaq, will waive advisory fees for both ETFs until December 17, 2021, which means that “the total expense ratio of each ETF is effectively reduced to 0 basis points”. “, It says in the press release.
“The addition of these two ETFs strengthens our already robust offering in the technology sector and the thematic industries within that sector,” said Paglia. “Invesco continues to expand its ETF offering to allow clients to choose the exposures that will help them get the best results.”
The inclusion of these new ETFs builds on that of Invesco Innovation suite, who owns the Invesco QQQ ETF (QQQ), the Invesco Nasdaq 100 ETF (QQQM), the Invesco Nasdaq-100 Index Fund (IVNQX) and the Invesco Nasdaq Next Gen 100 ETF (QQQJ).
“Nasdaq is proud to be the partner of a global community of leading healthcare and semiconductor companies,” said Lauren Dillard, Executive Vice President and Head of Investment Intelligence for Nasdaq. “We are excited to use our rules-based and transparent indices and look forward to building on our partnership with Invesco to offer investment products that enable investors to gain significant exposure to the groundbreaking companies that will change tomorrow.”
To learn more about the Nasdaq Biotechnology Index, read the latest research Here.
To learn more about the PHLX Semiconductor Sector Index, check out the latest research Here.